With approval for new drug, Alexion aims to switch patients from Soliris
Alexion Pharmaceuticals, Inc. | LinkedIn
AstraZeneca to buy Boston biotech Alexion for $39 billion in rare-disease push - The Boston Globe
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion
Alexion
Alexion
Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC | Fierce Pharma
Alexion Pharmaceuticals, Inc. | LinkedIn
Medicines | Alexion
Alexion
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion adds to pipeline rebuild with $855m Wilson buy - PMLiVE
Alexion
New Haven-based drugmaker acquires Swedish company
Astra Plots Post-Covid Future With $39 Billion Alexion Deal - Bloomberg
Alexion
Alexion (ALXN) to Acquire Wilson Therapeutics for $855M
Alexion
Alexion
Alexion
Alexion
Alexion announces a recommended public cash offer to the shareholders in Wilson Therapeutics
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion acquiring Achillion to expand reach into rare disease
